Close

Cell Therapeutics (CTIC) Sees Costs of $96M From Pacritinib Development Agreement (BAX)

November 18, 2013 6:32 AM EST Send to a Friend
Beginning on November 18, 2013, Cell Therapeutics, Inc. (Nasdaq: CTIC) plans to discuss with investors and analysts its Development, Commercialization ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login